The White House Office of Management and Budget has released a hold on NIH apportionments, allowing the National Institutes of Health to begin spending its 2026 research budget and issuing new competitive awards. NIH Director Jayanta “Jay” Bhattacharya confirmed the move during a House appropriations subcommittee hearing, saying the agency will distribute remaining funds and fill vacant leadership posts. Representative Rosa DeLauro flagged an earlier slowdown in awards and pressed OMB at the hearing; the reversal came after that congressional scrutiny. The funding unfreeze clears the way for new investigator-initiated grants and hiring that had been paused, reversing a bottleneck many biomedical groups blamed for a sharp drop in new grant competitions earlier this fiscal year. Operationally, the change matters for labs that delayed hiring and projects tied to FY2026 awards. Agency officials said prior spending this fiscal year had focused on renewals and essential obligations; NIH now expects new grant solicitations and awards to accelerate over the coming months. Stakeholders should expect an uptick in grant opportunities, filled leadership roles, and renewed publication and trial-support activity as NIH moves to deploy its $47.2 billion budget following OMB’s apportionment approval.